At the time of writing, PepGen Inc [PEPG] stock is trading at $2.50, up 19.90%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The PEPG shares have gain 9.65% over the last week, with a monthly amount glided 101.61%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
PepGen Inc [NASDAQ: PEPG] stock has seen the most recent analyst activity on December 16, 2024, when BofA Securities downgraded its rating to a Underperform but kept the price target unchanged to $3 for it. Previously, BofA Securities downgraded its rating to Neutral on July 31, 2024, and kept the price target unchanged to $12. On December 21, 2022, H.C. Wainwright initiated with a Buy rating and assigned a price target of $26 on the stock.
For the past year, the stock price of PepGen Inc fluctuated between $1.16 and $19.30. Currently, Wall Street analysts expect the stock to reach $29.5 within the next 12 months. PepGen Inc [NASDAQ: PEPG] shares were valued at $2.50 at the most recent close of the market. An investor can expect a potential return of 1080.0% based on the average PEPG price forecast.
Analyzing the PEPG fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -0.6, Equity is -0.61 and Total Capital is -0.73. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.16.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 2.18 points at the first support level, and at 1.85 for the second support level. However, for the 1st resistance point, the stock is sitting at 2.70, and for the 2nd resistance point, it is at 2.89.
Ratios To Look Out For
It is important to note that PepGen Inc [NASDAQ:PEPG] has a current ratio of 7.41. In addition, the Quick Ratio stands at 7.41 and the Cash Ratio stands at 2.96.
Transactions by insiders
Recent insider trading involved DeLena Mary Beth, General Counsel, that happened on Feb 26 ’25 when 1432.0 shares were sold. Chief Financial Officer, Donnelly Noel completed a deal on Feb 26 ’25 to sell 1527.0 shares. Meanwhile, Chief Medical Officer Mellion Michelle L sold 7571.0 shares on Jul 25 ’24.
